Skip to main content
Top
Published in: BMC Immunology 1/2008

Open Access 01-12-2008 | Research article

Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells

Authors: Jenny Persson, Jan Nilsson, Marie W Lindholm

Published in: BMC Immunology | Issue 1/2008

Login to get access

Abstract

Background

Pro-inflammatory cytokines can affect intracellular lipid metabolism. A variety of effects have been described for different cell types; hepatocyte lipid turnover pathways are inhibited during inflammation, whereas interleukin-1β (IL-1β) reduces intracellular cholesterol levels in fibroblasts. Levels of the pro-inflammatory cytokines IL-1β and tumour necrosis factor-α (TNF-α) are up-regulated at sites of formation of atherosclerotic plaques. Plaque formation is though to begin with infiltration of monocytes to the intimal layer of the vascular wall, followed by differentiation to macrophages and macrophage uptake of modified lipoproteins, resulting in accumulation of intracellular lipids. The lipid-filled cells are referred to as macrophage foam cells, a key feature of atherosclerotic plaques. We have investigated the effects of IL-1β and TNF-α on macrophage foam cells in order to assess whether presence of the pro-inflammatory cytokines improves or aggravates macrophage foam cell formation by affecting lipid accumulation and lipid turn-over in the cells.

Results

Differentiated primary human macrophages or THP-1 cells were lipid loaded by uptake of aggregated low density lipoproteins (AgLDL) or very low density lipoproteins (VLDL), and then incubated with IL-1β (0 – 5000 pg/ml) in lipoprotein-free media for 24 h. Cells incubated in absence of cytokine utilized accumulated neutral lipids, in particular triglycerides. Addition of exogenous IL-1β resulted in a dose-dependent retention of intracellular cholesterol and triglycerides. Exchanging IL-1β with TNF-α gave a similar response. Analysis of fatty acid efflux and intracellular fatty acid activation revealed a pattern of decreased lipid utilization in cytokine-stimulated cells.

Conclusion

IL-1β and TNF-α enhance macrophage foam cell formation, in part by inhibition of macrophage intracellular lipid catabolism. If present in vivo, these mechanisms will further augment the pro-atherogenic properties of the two cytokines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004, 45: 1169-96.CrossRefPubMed Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004, 45: 1169-96.CrossRefPubMed
2.
go back to reference Persson J, Degerman E, Nilsson J, Lindholm MW: Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun. 2007, 363: 1020-6.CrossRefPubMed Persson J, Degerman E, Nilsson J, Lindholm MW: Perilipin and adipophilin expression in lipid loaded macrophages. Biochem Biophys Res Commun. 2007, 363: 1020-6.CrossRefPubMed
3.
go back to reference Guyton JR, Klemp KF: Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb. 1994, 14: 1305-14.CrossRefPubMed Guyton JR, Klemp KF: Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler Thromb. 1994, 14: 1305-14.CrossRefPubMed
4.
go back to reference Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z: PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol. 2003, 14: 593-600.CrossRefPubMed Ruan XZ, Moorhead JF, Fernando R, Wheeler DC, Powis SH, Varghese Z: PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol. 2003, 14: 593-600.CrossRefPubMed
5.
go back to reference Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003, 44: 1728-36.CrossRefPubMed Khovidhunkit W, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR: Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res. 2003, 44: 1728-36.CrossRefPubMed
6.
go back to reference Grunfeld C, Feingold KR: Regulation of lipid metabolism by cytokines during host defense. Nutrition. 1996, 12: S24-6.PubMed Grunfeld C, Feingold KR: Regulation of lipid metabolism by cytokines during host defense. Nutrition. 1996, 12: S24-6.PubMed
7.
go back to reference Kruth HS, Skarlatos SI, Gaynor PM, Gamble W: Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. Journal Of Biological Chemistry. 1994, 269: 24511-8.PubMed Kruth HS, Skarlatos SI, Gaynor PM, Gamble W: Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. Journal Of Biological Chemistry. 1994, 269: 24511-8.PubMed
8.
go back to reference Zhang WY, Gaynor PM, Kruth HS: Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. Journal Of Biological Chemistry. 1996, 271: 28641-6.CrossRefPubMed Zhang WY, Gaynor PM, Kruth HS: Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. Journal Of Biological Chemistry. 1996, 271: 28641-6.CrossRefPubMed
9.
10.
go back to reference Zuckerman SH, Evans GF, O'Neal L: Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta. Atherosclerosis. 1992, 96: 203-14.CrossRefPubMed Zuckerman SH, Evans GF, O'Neal L: Cytokine regulation of macrophage apo E secretion: opposing effects of GM-CSF and TGF-beta. Atherosclerosis. 1992, 96: 203-14.CrossRefPubMed
11.
go back to reference Minor LK, Rothblat GH, Glick JM: Triglyceride and cholesteryl ester hydrolysis in a cell culture model of smooth muscle foam cells. J Lipid Res. 1989, 30: 189-97.PubMed Minor LK, Rothblat GH, Glick JM: Triglyceride and cholesteryl ester hydrolysis in a cell culture model of smooth muscle foam cells. J Lipid Res. 1989, 30: 189-97.PubMed
12.
go back to reference Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM: Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 1996, 16: 1000-6.CrossRefPubMed Galea J, Armstrong J, Gadsdon P, Holden H, Francis SE, Holt CM: Interleukin-1 beta in coronary arteries of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 1996, 16: 1000-6.CrossRefPubMed
13.
go back to reference Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990, 65: 297-302.CrossRefPubMed Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS: Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 1990, 65: 297-302.CrossRefPubMed
14.
go back to reference Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM: Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation. 2007, 116: 2043-52.CrossRefPubMed Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM: Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation. 2007, 116: 2043-52.CrossRefPubMed
15.
go back to reference Lindholm EM, Palmer AM, Graham A: Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages. Biochem J. 2001, 356: 515-23.PubMedCentralCrossRefPubMed Lindholm EM, Palmer AM, Graham A: Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages. Biochem J. 2001, 356: 515-23.PubMedCentralCrossRefPubMed
16.
go back to reference Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ: Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res. 1992, 33: 1551-61.PubMed Rumsey SC, Galeano NF, Arad Y, Deckelbaum RJ: Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins. J Lipid Res. 1992, 33: 1551-61.PubMed
17.
go back to reference Maor I, Aviram M: Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL. Atherosclerosis. 1999, 142: 57-66.CrossRefPubMed Maor I, Aviram M: Macrophage released proteoglycans are involved in cell-mediated aggregation of LDL. Atherosclerosis. 1999, 142: 57-66.CrossRefPubMed
18.
go back to reference Ohlsson BG, Englund MC, Karlsson AL, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest. 1996, 98: 78-89.PubMedCentralCrossRefPubMed Ohlsson BG, Englund MC, Karlsson AL, Knutsen E, Erixon C, Skribeck H, Liu Y, Bondjers G, Wiklund O: Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. J Clin Invest. 1996, 98: 78-89.PubMedCentralCrossRefPubMed
19.
go back to reference Persson J, Nilsson J, Lindholm MW: Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis. 2006, 5: 17-PubMedCentralCrossRefPubMed Persson J, Nilsson J, Lindholm MW: Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages. Lipids Health Dis. 2006, 5: 17-PubMedCentralCrossRefPubMed
20.
go back to reference Sjoblom L, Eklund A: Dietary protein and fatty acid composition of liver lipids in the rat. Biochim Biophys Acta. 1990, 1044: 187-92.CrossRefPubMed Sjoblom L, Eklund A: Dietary protein and fatty acid composition of liver lipids in the rat. Biochim Biophys Acta. 1990, 1044: 187-92.CrossRefPubMed
21.
go back to reference Tanaka T, Hosaka K, Numa S: Long-chain acyl-CoA synthetase from rat liver. Methods Enzymol. 1981, 71 (Pt C): 334-41.CrossRefPubMed Tanaka T, Hosaka K, Numa S: Long-chain acyl-CoA synthetase from rat liver. Methods Enzymol. 1981, 71 (Pt C): 334-41.CrossRefPubMed
22.
go back to reference Sambrook J, Fritsch EF, Maniatis T: Molecular cloning, a laboratory manual. 1989, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press Sambrook J, Fritsch EF, Maniatis T: Molecular cloning, a laboratory manual. 1989, Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press
Metadata
Title
Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells
Authors
Jenny Persson
Jan Nilsson
Marie W Lindholm
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2008
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-9-70

Other articles of this Issue 1/2008

BMC Immunology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine